Eisai - Industry Satellite Symposium: Eisai Scientific exchange symposium: Estrogen receptor positive (ER+) advanced breast cancer – What are the therapeutic approaches of the future? (ID 31) Industry Satellite Symposium

What are the broad strategies for mutation directed therapy? Is there a role for an orally-available Selective ER alpha Covalent Antagonist (SERCA)? (ID 819)

Lecture Time
12:10 - 12:40
Speakers
  • Dejan Juric (Boston, MA, United States of America)
Session Name
Eisai - Industry Satellite Symposium: Eisai Scientific exchange symposium: Estrogen receptor positive (ER+) advanced breast cancer – What are the therapeutic approaches of the future? (ID 31)
Location
Vienna Hall, MARITIM Hotel Berlin, Berlin, Germany
Date
02.05.2019
Time
12:00 - 13:00